Clinical and cytogenetic remission induced by interferon-α in a patient with chronic eosinophilic leukemia associated with a unique t(3;9;5) translocation

American Journal of Hematology

Volumn 58, Issue 2, 1998, Pages 137-141

  Yamada, Osamu ^a   Kitahara, Kouich ^b   Imamura, Kimiharu ^c   Ozasa, Hisashi ^d   Okada, Michiko ^e   Mizoguchi, Hideaki ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b SAKAKIBARA HEART INSTITUTE   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d Minami Ikebukuro Clinic   (Japan)

^e Chromosome Laboratory   (Japan)

Author keywords

Chronic eosinophilic leukemia; Complex translocation; Cytogenetic remission; Interferon alpha; Interleukin 5; t(3; 9; 5)

Indexed keywords

ALPHA INTERFERON; INTERLEUKIN 5;

ADULT; ARTICLE; CANCER REGRESSION; CASE REPORT; CHROMOSOME 5; CHROMOSOME TRANSLOCATION; CYTOGENETICS; CYTOKINE PRODUCTION; DRUG EFFECT; EOSINOPHILIC LEUKEMIA; HUMAN; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; ANTINEOPLASTIC AGENTS; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 5; CHROMOSOMES, HUMAN, PAIR 9; CHRONIC DISEASE; HUMANS; HYPEREOSINOPHILIC SYNDROME; INTERFERON-ALPHA; KARYOTYPING; MALE; REMISSION INDUCTION; RETREATMENT; TRANSLOCATION, GENETIC;

EID: 0031806213     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199806)58:2<137::AID-AJH9>3.0.CO;2-T     Document Type: Article

References (21)

1. Bain BJ: Eosinophilic leukemia and the idiopathic hypereosinophilic syndrome. Br J Haematol 95:2-9, 1996.
2. Talpaz M, Kantarjian HM, McCredie K, Trujillo JM, Keating MJ, Gutterman JU: Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia. N Engl J Med 314:1065-1069, 1986.
3. Smith AJ, van EL, de VE: Successful long-term control of idiopathic hypereosinophilic syndrome with etoposide. Cancer 67:2826-2837, 1991.
4. Goh MJ, Swisher SN, Rosenberg CA: Cytogenetic studies in eosinophilic leukemia. The relationship of eosinophilic leukemia and chronic myelogenous leukemia. Ann Intern Med 92:80-86, 1965.
5. Kwong YL, Chan LC: Involvement of eosinophils in acute myeloid leukaemia with monosomy 7 demonstrated by fluorescence in situ hybridization. Br J Haematol 88:389-391, 1994.
6. Ishibashi T, Kimura H, Abe R, Matsuda S, Uchida TKariyone S: Involvement of eosinophils in leukemia: Cytogenetic study of eosinophilic colonies from acute myelogenous leukemia associated with translocation (8;21). Cancer Genet Cytogenet 22:189-194, 1986.
7. Malbrain ML, Van den Bergh H, Zachee P: Further evidence for the clonal nature of the idiopathic hypereosinophilic syndrome: Complete haematological and cytogenetic remission induced by interferon-alpha in a case with a unique chromosomal abnormality. Br J Haematol 92:176-183, 1996.
8. Broxmeyer HE, Lu L, Platzer E, Feit C, Juliano L, Rubin BY: Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells. J Immunol 131:1300-1305, 1983.
9. Owen WF, Rothenberg ME, Petersen J, Weller PF, Silberstein D, Sheffer AL, Stevens RL, Soberman RJ, Austen KF: Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome. J Exp Med 170:343-348, 1989.
10. Aldebert D, Lamkhioued B, Desaint C, Gounni AS, Goldman M, Capron A, Prin L, Capron M: Eosinophils express a functional receptor for interferon alpha: Inhibitory role of interferon alpha on the release of mediators. Blood 87:2354-2360, 1996.
11. Saito H, Hayakawa T, Yui YShida T: Effect of human interferon on different functions of human neutrophils and eosinophils. Int Arch Allergy Appl Immunol 82:133-140, 1987.
12. Baranger L, Szapiro N, Gardais J, Hillion J, Derre J, Francois S, Blanchet O, Boasson MBerger R: Translocation t(5:12)(q31-q33;p12-p13): A non-random translocation associated with a myeloid disorder with eosinophilia. Br J Haematol 88:343-347, 1994.
13. da SM, Heerema N, Schwenk GJ, Hoffman R: Evidence for the clonal nature of hypereosinophilic syndrome. Cancer Genet Cytogenet 32: 109-115, 1988.
14. Sonoda Y, Arai Nogawa M: Humoral regulation of eosinophilopoiesis in vitro: Analysis of the targets of interleukin-3, granulocyte/ macrophage colony-stimulating factor (GM-CSF), and interleukin-5. Leukemia 3:14-18, 1989.
15. Sutherland GR, Baker E, Callen DF, Campbell HD, Young IG, Sanderson CJ, Garson OM, Lopez AF, Vadas MA: Interleukin-5 is at 5q31 and is deleted in the 5q-syndrome. Blood 71:1150-1152, 1988.
16. Huebner K, Isobe M, Croce CM, Golde DW, Kaufman SEGasson JC: The human gene encoding GM-CSF is at 5q21-q32, the chromosome region deleted in the 5q-anomaly. Science 230:1282-1285, 1985.
17. Yang YC, Kovacic S, Kriz R, Wolf S, Clark SC, Wellems TE, Nienhuis AEpstein N: The human genes for GM-CSF and IL 3 are closely linked in tandem on chromosome 5. Blood 71:958-961, 1988.
18. Golub TR, Barker GF, Lovett MGilliland DG: Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77:307-316, 1994.
19. Satoh T, Fantl WJ, Wscobedo JA, Williams LT, Kaziro Y: Platelet-derived growth factor receptor mediates activation of ras through different signaling pathways in different cell types. Mol Cell Biol 13: 3706-3713, 1993.
20. Valius M, Kazlauskas A: Phospholipase C-gammal and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic signal. Cell 73:321-334, 1993.
21. Claesson-Welsh L, Eriksson A, Moren A, Severinsson L, Ek B, Ostman A, Betsholtz C, Heldin C-H: cDNA cloning and expression of a human platelet-derived growth factor (PDGF) receptor specific for β-chain-containing PDGF molecules. Mol Cell Biol 8:3476-3486, 1988.